A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results

Pulmonary Pharmacology & Therapeutics
Fábio M HaggsträmCarlos C Fritscher

Abstract

Cognitive behavior therapy (CBT) constitutes the basis of smoking cessation programs. Quitting rates are usually increased by the concomitant use of CBT and pharmacotherapy. There are studies showing the efficacy of bupropion and nortriptyline compared to placebo, but there is just one published comparison between these drugs, unfortunately with low power to detect significant differences. This study was designed to compare the efficacy of bupropion, nortriptyline and placebo in a group of smokers who also received intensive counseling therapy. We conducted a double blind, double-dummy, placebo-controlled trial for smoking cessation that lasted 9 weeks. Patients were randomized to receive nortriptyline 75 mg/day (52 subjects), bupropion 300 mg/day (53 subjects) or placebo (51 subjects). All smokers also received the same intensive cognitive behavior therapy. The target day for quitting smoking was usually day 10. Intensive counseling was provided at baseline, weekly during treatment, and at 10, 13, 16, 20 and 26 weeks. Abstinence was defined as continuous when the subject was not smoking since the target-quitting day (self-report) and had an expired carbon monoxide concentration of 10 ppm or less. The sustained abstinence rates...Continue Reading

References

Apr 24, 1996·JAMA : the Journal of the American Medical Association
Oct 23, 1997·The New England Journal of Medicine·R D HurtP M Sullivan
Aug 26, 1998·Archives of General Psychiatry·S M HallE Triffleman
Oct 20, 1998·Archives of Internal Medicine·A V ProchazkaD Lofaso
Mar 4, 1999·The New England Journal of Medicine·D E JorenbyT B Baker
Aug 5, 2000·BMJ : British Medical Journal·P Jha, F J Chaloupka
Apr 13, 2001·Seminars in Oncology·E AlgrantiA C Achutti
Jun 14, 2001·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·J A JohnstonJ DeVeaugh-Geiss
Feb 15, 2002·The New England Journal of Medicine·Nancy A Rigotti
Jul 26, 2002·The New England Journal of Medicine·Christopher C Butler, Stephen Rollnick
Oct 9, 2002·Archives of General Psychiatry·Sharon M HallRoland Maude-Griffin
Jun 24, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·P A S do Prado-LimaI B M da Cruz
Oct 21, 2004·The Cochrane Database of Systematic Reviews·J HughesT Lancaster
Nov 10, 2004·Archives of Internal Medicine·Allan V ProchazkaGeorge E Fryer

❮ Previous
Next ❯

Citations

May 29, 2007·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Robert F LeemanStephanie S O'Malley
Jan 27, 2009·European Journal of Clinical Pharmacology·Adrienne Einarson, Sara Riordan
Oct 3, 2006·Expert Review of Neurotherapeutics·Kevin F FoleyRichard E Kast
Aug 31, 2006·Expert Opinion on Emerging Drugs·Robert A Schnoll, Caryn Lerman
Sep 12, 2015·Addiction·Jiraboon Tosanguan, Nathorn Chaiyakunapruk
Apr 12, 2015·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Ardita AlikoArjan Vissink
Jun 9, 2016·Expert Opinion on Pharmacotherapy·Jose L BarbozaKaren Suchanek Hudmon
Apr 1, 2008·Expert Review of Respiratory Medicine·K Michael Cummings, Martin C Mahoney
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Amanda C FarleyPaul Aveyard
Jan 10, 2014·The Cochrane Database of Systematic Reviews·John R HughesTim Lancaster
Jun 17, 2009·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·John D MeekerShanna H Swan
Feb 26, 2010·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Jan L LycheJanneche U Skaare
Apr 23, 2020·The Cochrane Database of Systematic Reviews·Seth HowesNicola Lindson
Apr 17, 2007·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·José Miguel Chatkin
Feb 22, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Teerapon DhippayomThitima Jongchansittho
Nov 15, 2008·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Jonatas ReichertUNKNOWN Sociedade Brasileira de Pneumologia e Tisiologia
Feb 8, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Archana MishraMonalisa Jena
Oct 7, 2021·The Cochrane Database of Systematic Reviews·Jamie Hartmann-BoycePaul Aveyard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.